W.H. Wilson Tang, MD

Article

Biomarkers: Their potential in the diagnosis and treatment of heart failure

Author:: W.H. Wilson Tang, MD

Publish date: December 1, 2015

Increased use of cardiac biomarkers have improved diagnosis and management of heart failure.

Article

The role of aldosterone receptor antagonists in the management of heart failure: An update

Author:: W.H. Wilson Tang, MD

Publish date: September 1, 2012

Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperka...

Article

In reply: Thiazolidinediones and heart failure

Author:: W.H. Wilson Tang, MD

Publish date: June 1, 2006

Article

New approaches to detect and manage edema and renal insufficiency in heart failure

Author:: W.H. Wilson Tang, MD

Publish date: June 1, 2006

Article

Panel discussion

Author:: W.H. Wilson Tang, MD

Publish date: June 1, 2006

Article

Do thiazolidinediones cause heart failure? A critical review

Author:: W.H. Wilson Tang, MD

Publish date: April 1, 2006

Although these drugs cause fluid retention, they may have benefits in patients with heart failure. This article outlines how to monitor for and man...

Article

In heart failure, all beta-blockers are not necessarily equal

Author:: W.H. Wilson Tang, MD

Publish date: December 1, 2003

Although survival was better with carvedilol than with immediate-release metoprolol tartrate, we must increase the use of any approved beta-blocker...